Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.83B
Enterprise Value5.55B
P/E Ratio-15.61
PEG Ratio-0.2
Price/Sales Ratio1.75
Price/Book Ratio1.4
Enterprise/Revenue1.75
Enterprise/EBITDA-24.25

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.11
AD

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.09

Income Statement

Revenue2.77B
Revenue/Share2.7
Gross Profit1.3B
EBITDA-148.37M
Net Income-301.06M
Diluted EPS-0.3

Balance Sheet

Total Cash782.89M
Total Cash/Share0.79
Total Debt254.64M
Total Debt/Equity0.08
Current Ratio2.32
Book Value Per Share3.33

Price History

52-Week Change6.8
52-Week High10.27
52-Week Low4.24
Moving Average 50 Days5.56
Moving Average 200 Days6.19

Statistics

Average Volume22.02M
Shares Outstanding992.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor2:1
Last Split DateJune 14, 2018
AD